David Navarro to Ribavirin
This is a "connection" page, showing publications David Navarro has written about Ribavirin.
Connection Strength
0.101
-
A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study. Transpl Infect Dis. 2017 Aug; 19(4).
Score: 0.101